IP Library Assignment 029321/0739
Patent Assignment
Reel/Frame 029321/0739

Assignment of Assignor's Interest

Recorded: 2012-11-19 Pages: 6
Assignor
ALPHA SYNERGY DEVELOPMENT, INC.
Executed: 2012-10-15
Assignee
EYE THERAPIES LLC
26933 CAMINO DE ESTRELLA, 2ND FLOOR, DANA POINT, CALIFORNIA, 92624
Covered Properties (19)
Vasoconstriction Compositions and Methods of Use
Compositions and Methods for Eye Whitening
Compositions and Methods for Ophthalmic Delivery of Nasal Decongestants
Compositions and Methods for Treatment of Pulmonary Diseases and Conditions
Compositions and Methods for the Treatment of Nasal Conditions
Multi-functional tool and method of using same
Application: 12/460,491 →
Publication: US 2011/0010933
Compositions and Methods for Reversing Rebound Hyperemia
Patent: 8,338,421 →
Application: 12/460,942 →
Publication: US 2010/0029660
Anesthetic Compositions and Methods of Use
Patent: 8,080,550 →
Application: 12/460,954 →
Publication: US 2010/0029661
Vasoconstriction compositions and methods of use
Application: 12/460,967 →
Publication: US 2010/0029662
Compositions and Methods for Reducing Activation of Alpha-1 Receptors
Patent: 8,580,787 →
Application: 12/460,968 →
Publication: US 2010/0029663
Composition and methods for treating allergic response
Application: 12/460,969 →
Publication: US 2010/0028266
Compositions and Methods for Reducing Capillary Permeability
Patent: 8,283,350 →
Application: 12/460,970 →
Publication: US 2010/0028267
Compositions and methods for treatment of diseases and conditions with increased vascular permeability
Application: 12/798,929 →
Publication: US 2010/0197694
Compositions and methods for treatment of diseases and conditions associated with vasodilation and/or vascular leakage
Application: 12/800,942 →
Publication: US 2011/0003823
Compositions and Methods for Eye Whitening
Patent: 8,765,758 →
Application: 12/928,749 →
Publication: US 2011/0160214
Compositions and methods for treatment of pulmonary diseases and conditions
Application: 13/066,368 →
Publication: US 2011/0244058
Compositions and methods for the treatment of nasal conditions
Application: 13/066,370 →
Publication: US 2011/0257188
Nasal Compositions and Uses Thereof
Application: 13/406,321 →
Publication: US 2012/0156244
Compositions and Methods for Improving Night Vision
Application: 13/458,559 →
Publication: US 2012/0277239
Related Assignments (13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 27, 2009
From: HORN, GERALD
To: ALPHA SYNERGY DEVELOPMENT, INC.
Reel/Frame 023054/0343 →
Assignment of Assignor's Interest Jul 27, 2009
From: HORN, GERALD
To: ALPHA SYNERGY DEVELOPMENT, INC.
Reel/Frame 023054/0263 →
Assignment of Assignor's Interest Jul 27, 2009
From: HORN, GERALD
To: ALPHA SYNERGY DEVELOPMENT, INC.
Reel/Frame 023059/0923 →
Assignment of Assignor's Interest Jul 27, 2009
From: HORN, GERALD
To: ALPHA SYNERGY DEVELOPMENT, INC.
Reel/Frame 023059/0846 →
Assignment of Assignor's Interest Jul 27, 2009
From: HORN, GERALD
To: ALPHA SYNERGY DEVELOPMENT, INC.
Reel/Frame 023059/0096 →
Assignment of Assignor's Interest Jul 27, 2009
From: HORN, GERALD
To: ALPHA SYNERGY DEVELOPMENT, INC.
Reel/Frame 023059/0950 →
Assignment of Assignor's Interest Sep 14, 2010
From: HORN, GERALD
To: ALPHA SYNERGY DEVELOPMENT, INC.
Reel/Frame 024983/0168 →
Assignment of Assignor's Interest Sep 14, 2010
From: HORN, GERALD
To: ALPHA SYNERGY DEVELOPMENT, INC.
Reel/Frame 024980/0932 →
Assignment of Assignor's Interest Jun 21, 2011
From: HORN, GERALD
To: ALPHA SYNERGY DEVELOPMENT, INC.
Reel/Frame 026474/0168 →
Assignment of Assignor's Interest Jul 1, 2011
From: HORN, GERALD
To: ALPHA SYNERGY DEVELOPMENT, INC.
Reel/Frame 026535/0454 →
Assignment of Assignor's Interest Mar 16, 2012
From: HORN, GERALD
To: ALPHA SYNERGY DEVELOPMENT, INC.
Reel/Frame 027878/0386 →
Assignment of Assignor's Interest Dec 30, 2014
From: HORN, GERALD
To: ALPHA SYNERGY DEVELOPMENT, INC.
Reel/Frame 034599/0049 →
Assignment of Assignor's Interest Nov 19, 2015
From: EYE THERAPIES LLC
To: PS THERAPIES LTD
Reel/Frame 037083/0739 →